membran
fusion
process
mediat
sever
acut
respiratori
syndrom
coronaviru
sarscov
protein
cellular
receptor
angiotensinconvert
enzym
reconstitut
use
two
chines
hamster
ovari
cho
cell
line
constitut
express
recombin
protein
separ
system
appli
develop
quantit
measur
cellcel
fusion
use
hepat
c
viru
hcv
proteas
secretionblock
egfp
enhanc
green
fluoresc
protein
decapeptid
substrat
proteas
seap
secret
alkalin
phosphatas
fusion
gene
gene
transient
express
either
cho
cell
line
follow
fusion
treatment
signific
seap
activ
could
detect
cultur
medium
cellcel
fusion
occur
cellcel
fusion
provid
environ
proteas
encount
substrat
therebi
releas
seap
fusion
protein
studi
develop
simpl
sensit
quantit
assay
studi
membran
fusion
process
measur
extracellular
activ
seap
use
hepat
c
viru
secret
alkalin
phosphatas
quantit
cellcel
membran
fusion
mediat
sever
acut
respiratori
syndrom
coronaviru
protein
receptor
angiotensinconvert
enzym
cellular
membran
fusion
essenti
process
cell
physiolog
eukaryot
system
crucial
intracellular
traffick
cell
secret
exoand
endocytosi
entri
envelop
anim
virus
cell
biolog
solubl
nethylmaleimidesensit
factor
attach
protein
receptor
snare
implic
membran
fusion
decad
greatli
elucid
correspondingli
envelop
virus
human
immunodefici
influenza
herp
vaccinia
hepat
c
virus
wide
studi
mechan
cellular
entri
virus
unload
genom
host
cytoplasm
viruscel
membran
fusion
process
initi
viral
replic
cycl
entri
sever
acut
respiratori
syndrom
coronaviru
sarscov
recent
identifi
human
coronaviru
also
membran
fusiondepend
event
mediat
virion
surfac
spike
protein
cellular
receptor
angiotensinconvert
enzym
see
front
matter
elsevi
inc
demonstr
previou
studi
cellular
surfac
express
recombin
protein
use
mimic
membran
fusion
process
provid
safe
simpl
assay
character
abil
anti
monoclon
antibodi
block
viral
infect
current
studi
use
noninfect
chines
hamster
ovari
cho
cell
develop
system
allow
accur
quantif
cellcel
membran
fusion
process
highli
sensit
report
low
background
endogen
alkalin
phosphatas
secret
alkalin
phosphatas
seap
secret
cultur
medium
use
quantit
analysi
membran
fusion
without
interf
cellular
activ
secret
could
block
seap
tag
enhanc
green
fluoresc
protein
egfp
n
terminu
proteas
substrat
linker
egfp
seap
design
releas
phosphatas
wherea
linker
decapeptid
boundari
hepat
c
viru
hcv
gene
access
proteas
hcv
envelop
positivestrand
rna
viru
genom
encod
uniqu
polyprotein
precursor
must
process
proteas
produc
individu
viral
protein
hcv
nonstructur
protein
serinetyp
proteas
cofactor
requir
cleavag
junction
ns
protein
except
within
polyprotein
use
unblock
tag
seap
cut
linker
studi
quantit
method
develop
express
proteas
egfptag
seap
differ
fusion
partner
cho
cell
two
cho
stabl
cell
line
chosg
constitut
express
either
fusion
modul
transient
transfect
mix
treat
trypsin
format
syncytium
observ
extracellular
activ
seap
could
measur
due
access
proteas
recognit
sequenc
cell
line
cellcel
membran
fusion
five
stabl
cell
line
chosg
establish
cell
line
american
type
cultur
collect
atcc
atcc
cell
line
cultur
co
dulbecco
modifi
eagl
medium
dmem
contain
g
l
glucos
mg
ml
streptomycin
u
ml
penicillin
fetal
bovin
serum
fb
hyclon
addit
mg
ml
gibcobrl
stabl
cell
line
construct
chosg
describ
previous
hcv
gene
ectodomain
protein
hcv
polyprotein
amino
acid
sequenc
amplifi
templat
nation
center
biotechnolog
inform
ncbi
access
primer
pcr
fragment
doubl
digest
bgliiswai
insert
plasmid
treatment
ectodomain
segfp
replac
ectodomain
produc
cytoplasm
transmembran
domain
plu
amino
acid
residu
outward
juxtamembran
region
protein
fuse
protein
stabl
cell
line
establish
use
lipofectamin
invitrogen
transfect
reagent
select
highyield
clone
select
use
fluoresc
microscop
fit
fluorescein
isothiocyan
fitc
filter
instead
make
gs
singl
plasmid
construct
kpninoti
site
clontech
separ
hcv
amplifi
templat
primer
gcggtaccgcc
acc
gcgc
gs
amplifi
three
pcr
use
egfp
seap
templat
three
set
primer
see
supplementari
materi
mutat
modif
gs
make
gskr
gd
gdsx
also
pcr
amplifi
use
three
set
primer
see
supplementari
materi
pcr
product
confirm
sequenc
doubl
digest
bsrgi
bamhi
replac
bsrgi
bamhi
fragment
gs
construct
gskr
gd
gdsx
confluent
gd
transient
transfect
cell
dislodg
edta
wash
phosphatebuff
salin
pb
cell
pellet
resuspend
serumfre
cultur
medium
overlaid
ratio
confluent
cell
layer
cultur
chosg
transient
transfect
chosg
cell
cell
allow
settl
h
lg
ml
porcin
trypsin
jrh
bioscienc
ad
initi
membran
fusion
process
describ
previous
h
later
cell
observ
microscop
syncytium
format
transfect
extracellular
seap
assay
western
blot
analysi
cho
cultur
confluenc
cotransfect
per
manufactur
instruct
lipofectamin
invitrogen
plasmid
plasmid
ratio
gs
gsk
gsr
gd
gdsg
gdse
gdsr
seap
releas
effect
proteas
cho
cell
also
cotransfect
plasmid
mix
either
gd
gs
gd
alon
seap
activ
furthermor
transfect
gd
wherea
chosg
neg
control
transfect
cellcel
fusion
assay
perform
without
trypsin
seap
assay
perform
follow
manufactur
instruct
clontech
chemiluminesc
detect
use
plate
reader
microbeta
trilux
perkinelm
media
sampl
seap
assay
collect
transient
transfect
cell
quantit
cellular
fusion
process
perform
triplic
three
individu
experi
transient
transfect
cho
cell
lyse
sdspage
standard
reduc
sampl
buffer
boil
lysat
separ
sdspage
transfer
nitrocellulos
hybondc
membran
amersham
bioscienc
western
blot
analysi
prestain
molecular
marker
purchas
invitrogen
membran
block
nonfat
milk
pbst
pb
contain
tween
membran
treat
primari
monoclon
antibodi
specif
gfp
roch
follow
secondari
horseradish
peroxidas
hrp
conjug
sheep
antimous
antibodi
pierc
detect
base
chemiluminesc
supersign
west
pico
chemiluminesc
substrat
pierc
interact
protein
sarscov
cellular
receptor
demonstr
essenti
cellular
bind
membran
fusion
two
separ
cho
stabl
cell
line
establish
previous
use
reconstitut
cellcel
fusion
process
express
human
chosg
express
sarscov
protein
surfac
express
chosg
cell
shown
nonperm
immunofluoresc
assay
ifa
use
serum
sar
convalesc
patient
bind
chosg
vero
cell
present
cell
line
specif
block
either
serum
sar
patient
goat
antibodi
cellular
surfac
express
cell
shown
fluorescenceactiv
cell
sort
fac
analysi
also
establish
three
cell
line
use
confirm
cellcel
membran
fusion
process
mediat
use
neg
control
cell
line
establish
way
chosg
use
cell
transfect
host
establish
express
hcv
protein
red
fluoresc
protein
rfp
tag
c
terminu
see
supplementari
fig
ctermin
tag
egfp
see
supplementari
fig
determin
whether
cellcel
membran
fusion
occur
cell
overlaid
onto
monolay
cell
express
either
treat
trypsin
initi
fusion
process
h
trypsin
treatment
cellcel
membran
fusion
occur
cell
well
cell
fig
c
contrast
cell
inert
treatment
fig
fusion
process
requir
trypsin
treatment
empir
essenti
agreement
previou
studi
gene
construct
quantit
measur
seap
report
hcv
ns
ns
use
quantit
fusion
process
block
secretori
charact
seap
egfp
tag
n
terminu
via
decapeptid
linker
demeecash
correspond
proteas
cleavag
site
junction
tag
seap
could
unblock
releas
extracellularli
proteas
fusion
encount
cell
plasmid
express
gs
construct
fig
increas
access
linker
proteas
mutat
modif
around
proteas
cleavag
site
gener
fig
fourth
amino
acid
residu
seap
signal
peptid
mutat
lysin
gsk
arginin
gsr
octapeptid
dededed
intercal
egfp
sequenc
construct
gd
furthermor
fourth
amino
acid
residu
seap
signal
peptid
gd
mutat
leucin
glycin
gdsg
glutam
acid
gdse
arginin
gdsr
amount
seap
activ
cultur
supernat
cho
cell
transient
transfect
gs
neg
control
cotransfect
gs
gsk
gsr
gd
gdsg
gdse
gdsr
measur
h
transfect
fig
gs
leucin
mutant
gsk
gsr
express
near
basal
level
extracellular
seap
activ
indic
linker
might
readili
access
proteas
probabl
close
hydrophob
core
seap
signal
peptid
hydrophob
region
egfp
c
terminu
fig
inde
cotransfect
gd
signific
amount
seap
activ
detect
cultur
supernat
contribut
extra
octapeptid
cotransfect
leucin
mutat
gd
deriv
gdsg
gdse
gdsr
also
yield
signific
level
extracellular
seap
activ
level
lower
gd
cleavag
activ
gs
gd
determin
use
western
blot
analysi
fig
proteas
present
partial
activ
gs
wherea
digest
gd
nearli
complet
express
level
gs
gd
also
differ
load
gs
sampl
fig
five
time
less
gd
sampl
unblock
effect
gd
proteas
test
hightransfect
effici
cell
line
fig
seap
activ
gs
gd
cotransfect
gd
alon
compar
among
cho
cell
seap
releas
gd
cho
cell
significantli
greater
cell
therefor
chosg
cell
express
gd
respect
chosen
develop
quantit
assay
cellcel
membran
fusion
process
see
gskr
construct
fourth
amino
acid
residu
x
indic
mutat
leucin
lysin
arginin
gdsx
construct
x
repres
glycin
glutam
acid
arginin
gd
construct
intercal
octapeptid
dededed
upstream
chosg
cell
transfect
high
level
extracellular
seap
detect
cultur
supernat
mix
cultur
gd
chosg
trypsin
treatment
fig
indic
fusion
chosg
see
fig
allow
proteas
access
cleav
linker
gd
would
expect
signific
secret
seap
media
mix
cultur
transfect
either
neg
control
transfect
transfect
chosg
cell
without
trypsin
treatment
result
indic
clearli
gd
could
use
quantit
measur
cellcel
membran
fusion
seap
gs
construct
significantli
releas
proteas
cellular
environ
membran
compartment
may
limit
factor
sequenc
gs
analyz
use
tmpred
servic
wwwchembnetorg
predict
possibl
transmembran
region
signal
peptid
mlllllllg
lrlqlslgi
seap
strongli
indic
transmembran
domain
may
affect
access
linker
sequenc
proteas
digest
hand
rang
amino
acid
residu
egfp
c
terminu
also
suggest
possibl
transmembran
domain
although
egfp
known
cytoplasm
protein
behavior
may
differ
fusion
protein
increas
access
linker
proteas
activ
first
tri
make
minimum
modif
mutat
one
amino
acid
residu
seap
signal
peptid
abolish
put
transmembran
domain
maintain
signal
peptid
analysi
amino
acid
residu
compris
signal
sequenc
use
program
signalp
wwwcbsdtudk
servicessignalp
suggest
chang
fourth
residu
leucin
either
lysin
gsk
arginin
gsr
howev
modif
increas
extracellular
seap
activ
fact
could
hinder
process
decreas
secret
effici
gdsg
gdse
gdsr
fig
tri
increas
proteas
access
insert
hydrophil
peptid
egfp
leav
signal
peptid
intact
four
neg
charg
amino
acid
residu
neg
charg
octapeptid
design
compos
asp
glu
amino
acid
residu
limit
interact
make
extra
distanc
hydrophob
region
egfp
protean
program
dnastar
use
compar
predict
hydrophil
surfac
probabl
gs
gsk
gd
fig
insert
octapeptid
gd
inde
increas
comput
profil
region
possibl
increas
proteas
access
result
cotransfect
gd
cho
cell
support
view
access
howev
octapeptid
might
optimum
chogd
stabl
clone
still
express
basal
level
extracellular
seap
transfect
see
supplementari
fig
secret
seap
gd
cotransfect
cell
insignific
paramet
octapeptid
could
possibl
chang
length
modifi
hydrophil
amino
acid
residu
cellular
fusion
cell
drastic
chosg
cell
quantit
limit
low
transfect
effici
cell
addit
promot
strong
enough
drive
transient
express
either
gd
cell
quantit
measur
avail
laboratori
also
establish
chogd
stabl
cell
line
cellcel
membran
fusion
quantit
studi
transient
express
either
suffici
perform
process
significantli
make
use
proteas
activ
hcv
protein
design
novel
substrat
gd
develop
quantit
assay
membran
fusion
process
sarscov
cellular
receptor
quantit
system
could
use
analyz
fine
detail
import
step
sarscov
life
cycl
could
also
provid
safe
simpl
assay
highthroughput
screen
identifi
inhibitor
stop
viru
crucial
step
similarli
assay
could
adapt
studi
membran
fusion
process
envelop
virus
estim
million
peopl
chronic
infect
hcv
develop
effect
hcv
therapi
still
challeng
due
lack
adequ
anim
model
tissu
cultur
system
analysi
propag
viru
howev
develop
subgenom
hcv
replicon
system
critic
enabl
preclin
evalu
potenti
antihcv
agent
support
drug
discoveri
macrocycl
inhibitor
biln
identifi
use
substratebas
approach
design
inhibitor
hcv
activ
site
subsequ
identifi
inhibitor
mutant
base
studi
use
replicon
system
quantit
method
use
gd
could
use
altern
way
screen
hcv
inhibitor
vivo
facilit
studi
drugresist
mutant
quantit
measur
articl
present
cellcel
membran
fusion
mediat
two
stabl
cho
cell
line
express
recombin
sarscov
protein
human
individu
moreov
fusion
process
use
model
develop
quantit
measur
extracellular
seap
via
transient
express
hcv
proteas
gd
secret
block
seap
cell
line
separ
